Schedule 13G ownership disclosure

Korro Bio Inc

Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 500946108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Citadel Advisors LLC

    Shares: 369,733.00 · Class: 3.9%

  • Citadel Advisors Holdings LP

    Shares: 369,733.00 · Class: 3.9%

  • Citadel GP LLC

    Shares: 369,733.00 · Class: 3.9%

  • Citadel Securities LLC

    Shares: 0.00 · Class: 0.0%

  • Citadel Securities Group LP

    Shares: 0.00 · Class: 0.0%

  • Citadel Securities GP LLC

    Shares: 0.00 · Class: 0.0%

  • Kenneth Griffin

    Shares: 369,733.00 · Class: 3.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014358
Form type
SCHEDULE 13G/A
Filer
CITADEL ADVISORS LLC
CIK
CIK 1423053
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub